Eli Lilly Corp. buy Scotiabank
Start price
05.02.26
/
50%
€875.30
Target price
05.02.27
-
Performance (%)
-7.30%
Price
02.04.26
€811.40
Summary
This prediction is currently active. With a performance of -7.30%, the BUY prediction for Eli Lilly Corp. by Scotiabank is down slightly. This prediction currently runs until 05.02.27. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 4.079% | 4.079% |
| iShares Core DAX® | 2.489% | -5.941% |
| iShares Nasdaq 100 | 1.649% | -2.462% |
| iShares Nikkei 225® | 0.555% | -7.597% |
| iShares S&P 500 | 1.347% | -2.943% |
Comments by Scotiabank for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Scotiabank.
Ratings data for LLY provided by MarketBeat